Evidence map›Paper›PMID 29130426›Full record

ArticleAutophagy2018

NUPR1 maintains autolysosomal efflux by activating SNAP25 transcription in cancer cells.

Yanchao Mu, Xiaojie Yan, Ding Li, Dan Zhao, Lingling Wang, Xiaoyang Wang, Dan Gao, Jie Yang, Hua Zhang, Yanzhe Li and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 98 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 2 countries.

Yanchao Mua 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics , Tianjin Key Laboratory of Medical Epigenetics, Department of Immunology , Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University , Tianjin , China.
Xiaojie Yana 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics , Tianjin Key Laboratory of Medical Epigenetics, Department of Immunology , Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University , Tianjin , China.
Ding Lic Laboratory of Epigenetics and Tumorigenesis, Tianjin Research Center of Basic Medical Sciences , Tianjin Medical University , Tianjin , 22 Qixiangtai Road, Heping District, Tianjin , China.
Dan Zhaoa 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics , Tianjin Key Laboratory of Medical Epigenetics, Department of Immunology , Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University , Tianjin , China.
Lingling Wanga 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics , Tianjin Key Laboratory of Medical Epigenetics, Department of Immunology , Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University , Tianjin , China.
Xiaoyang Wanga 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics , Tianjin Key Laboratory of Medical Epigenetics, Department of Immunology , Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University , Tianjin , China.
Dan Gaoa 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics , Tianjin Key Laboratory of Medical Epigenetics, Department of Immunology , Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University , Tianjin , China.
Jie Yanga 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics , Tianjin Key Laboratory of Medical Epigenetics, Department of Immunology , Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University , Tianjin , China.
Hua Zhanga 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics , Tianjin Key Laboratory of Medical Epigenetics, Department of Immunology , Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University , Tianjin , China.
Yanzhe Lia 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics , Tianjin Key Laboratory of Medical Epigenetics, Department of Immunology , Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University , Tianjin , China.
Yanan Suna 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics , Tianjin Key Laboratory of Medical Epigenetics, Department of Immunology , Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University , Tianjin , China.
Yiliang Weia 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics , Tianjin Key Laboratory of Medical Epigenetics, Department of Immunology , Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University , Tianjin , China.
Zhenfa Zhangf Department of Lung Cancer , Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital , Tianjin , China.
Xinzhong Changg Department of Breast Cancer , Breast Cancer Center, Tianjin Medical University Cancer Institute and Hospital , Tianjin , China.
Zhi Yaoa 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics , Tianjin Key Laboratory of Medical Epigenetics, Department of Immunology , Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University , Tianjin , China.
Shanshan Tiana 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics , Tianjin Key Laboratory of Medical Epigenetics, Department of Immunology , Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University , Tianjin , China.
Kai Zhanga 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics , Tianjin Key Laboratory of Medical Epigenetics, Department of Immunology , Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University , Tianjin , China.
Lance S Teradah Department of Internal Medicine, Division of Pulmonary and Critical Care , University of Texas Southwestern Medical Center , Dallas , TX , USA.
Zhenyi Maa 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics , Tianjin Key Laboratory of Medical Epigenetics, Department of Immunology , Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University , Tianjin , China.ORCID 0000-0001-6962-2711
Zhe Liua 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics , Tianjin Key Laboratory of Medical Epigenetics, Department of Immunology , Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University , Tianjin , China.
Tianjin Medical University · CNTianjin Medical University Cancer Institute and Hospital · CNFifth Hospital of Shijiazhuang · CNThe University of Texas Southwestern Medical Center · US

Funding

(PQ1) Epigenetic effects of the premalignant fieldR01CA208620 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI TERADA, LANCE S · 2016 to 2020
$1.9M
NCI NIH HHS R01 CA208620
6 · The paper itself

Abstract

In the advanced stages of cancer, autophagy is thought to promote tumor progression through its ability to mitigate various cellular stresses. However, the details of how autophagy is homeostatically regulated in such tumors are unknown. Here, we report that NUPR1 (nuclear protein 1, transcriptional regulator), a transcriptional coregulator, is aberrantly expressed in a subset of cancer cells and predicts low overall survival rates for lung cancer patients. NUPR1 regulates the late stages of autolysosome processing through the induction of the SNARE protein SNAP25, which forms a complex with the lysosomal SNARE-associated protein VAMP8. NUPR1 depletion deregulates autophagic flux and impairs autolysosomal clearance, inducing massive cytoplasmic vacuolization and premature senescence in vitro and tumor suppression in vivo. Collectively, our data show that NUPR1 is a potent regulator of autolysosomal dynamics and is required for the progression of some epithelial cancers.

Indexed as

AutophagyBasic Helix-Loop-Helix ProteinsGene Expression Regulation, NeoplasticHumansLung NeoplasmsLysosomesNeoplasm ProteinsSynaptosomal-Associated Protein 25Basic Helix-Loop-Helix ProteinsNeoplasm ProteinsNUPR1 protein, humanSNAP25 protein, humanSynaptosomal-Associated Protein 25autolysosomal effluxNUPR1premature senescenceSNAP25transcriptional regulator

Identifiers

PMID29130426
PMCPMC5959327
OpenAlexW2770409448

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.